US Stock MarketDetailed Quotes

CLVS Clovis Oncology

Watchlist
  • 0.0812
  • 0.00000.00%
Close Dec 20 16:00 ET
11.77MMarket Cap-44P/E (TTM)

Clovis Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.85%-40.61M
24.87%-35.13M
5.49%-58.5M
22.42%-196.06M
26.24%-41.34M
15.20%-46.07M
21.89%-46.76M
24.98%-61.89M
21.90%-252.73M
20.09%-56.05M
Net income from continuing operations
16.90%-56.02M
-7.35%-71.33M
9.22%-60.17M
28.35%-264.52M
34.93%-64.39M
14.32%-67.41M
27.97%-66.45M
33.28%-66.28M
7.79%-369.21M
0.55%-98.96M
Operating gains losses
----
----
----
----
----
----
----
----
117.73%3.28M
--0
Depreciation and amortization
-6.53%1.89M
-14.93%1.9M
-14.19%1.92M
3.64%8.5M
-2.58%2M
0.05%2.02M
11.96%2.24M
5.21%2.24M
5.54%8.2M
0.49%2.05M
Other non cash items
11,587.50%935K
-42.86%944K
-38.92%926K
-88.85%4.25M
-96.21%1.07M
-98.76%8K
159.34%1.65M
-82.32%1.52M
44.22%38.09M
459.68%28.23M
Change In working capital
-49.68%6.2M
116.10%18.24M
-129.01%-7.81M
153.17%30.27M
2,069.13%12.93M
33.86%12.31M
-31.97%8.44M
66.73%-3.41M
43.56%11.96M
-97.48%596K
-Change in receivables
3.52%-1.86M
437.23%8.1M
-116.17%-765K
86.20%-746K
79.99%-1.15M
5.48%-1.93M
-134.91%-2.4M
204.71%4.73M
28.08%-5.41M
-60.46%-5.72M
-Change in inventory
95.09%4.81M
95.03%5.58M
0.55%3.69M
136.31%12.57M
206.31%3.59M
-43.21%2.46M
215.23%2.86M
-46.41%3.67M
120.34%5.32M
-5.14%-3.37M
-Change in prepaid assets
-251.79%-2.88M
-110.57%-8.13M
-162.26%-1.32M
38.79%-5.09M
-12,113.95%-5.25M
164.58%1.9M
-130.63%-3.86M
111.85%2.13M
-135.78%-8.31M
-100.43%-43K
-Change in payables and accrued expense
-68.45%3.2M
-28.68%7.7M
49.31%-4.53M
177.92%26.47M
306.69%14.47M
-8.65%10.13M
304.31%10.8M
-5,381.66%-8.93M
-62.81%9.53M
-83.32%3.56M
-Change in other working capital
1,291.50%2.94M
379.27%4.99M
2.52%-4.88M
-127.15%-2.94M
-79.45%1.27M
80.08%-247K
49.50%1.04M
-196.29%-5.01M
258.42%10.83M
819.81%6.18M
Cash from discontinued investing activities
Operating cash flow
11.85%-40.61M
24.87%-35.13M
5.49%-58.5M
22.42%-196.06M
26.24%-41.34M
15.20%-46.07M
21.89%-46.76M
24.98%-61.89M
21.90%-252.73M
20.09%-56.05M
Investing cash flow
Cash flow from continuing investing activities
0.00%-89K
-27.78%-46K
47.46%-62K
-100.25%-312K
73.46%-69K
-368.42%-89K
-100.06%-36K
-100.17%-118K
-11.90%126.33M
-101.55%-260K
Net PPE purchase and sale
0.00%-89K
-27.78%-46K
47.46%-62K
11.86%-312K
73.46%-69K
-368.42%-89K
12.20%-36K
-247.06%-118K
88.26%-354K
35.48%-260K
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
49.21%-8M
--0
Net investment purchase and sale
----
----
----
--0
----
----
----
----
-16.95%134.68M
--0
Cash from discontinued investing activities
Investing cash flow
0.00%-89K
-27.78%-46K
47.46%-62K
-100.25%-312K
73.46%-69K
-368.42%-89K
-100.06%-36K
-100.17%-118K
-11.90%126.33M
-101.55%-260K
Financing cash flow
Cash flow from continuing financing activities
150.12%6.18M
-89.36%9.14M
183.02%37.86M
-50.82%100.16M
-81.67%13.17M
-176.29%-12.33M
-14.92%85.94M
-8.66%13.38M
69.86%203.64M
443.96%71.84M
Net issuance payments of debt
111.47%6.18M
-31.63%8.76M
-30.92%9.22M
59.56%-17.95M
-86.36%9.73M
-432.03%-53.84M
-26.01%12.81M
108.94%13.35M
-138.06%-44.39M
472.29%71.34M
Net common stock issuance
--0
-100.01%-8K
--28.64M
-52.60%116.92M
--2.94M
70,466.10%41.52M
-12.50%72.47M
--0
--246.67M
--0
Proceeds from stock option exercised by employees
--0
-40.24%392K
--0
-13.22%1.18M
1.01%499K
--0
-24.25%656K
1,250.00%27K
-58.30%1.36M
-33.24%494K
Cash from discontinued financing activities
Financing cash flow
150.12%6.18M
-89.36%9.14M
183.02%37.86M
-50.82%100.16M
-81.67%13.17M
-176.29%-12.33M
-14.92%85.94M
-8.66%13.38M
69.86%203.64M
443.96%71.84M
Net cash flow
Beginning cash position
-58.92%94.58M
-35.97%122.24M
-40.30%143.43M
48.44%240.23M
-23.48%171.95M
-11.95%230.2M
16.91%190.92M
48.44%240.23M
-27.06%161.83M
11.53%224.7M
Current changes in cash
40.97%-34.52M
-166.49%-26.03M
57.44%-20.7M
-224.56%-96.21M
-281.96%-28.25M
-53.16%-58.48M
-60.03%39.15M
-2,585.03%-48.63M
228.04%77.24M
138.64%15.52M
Effect of exchange rate changes
-858.95%-1.74M
-1,327.82%-1.63M
27.85%-487K
-151.13%-589K
-7,000.00%-276K
-84.23%229K
-24.86%133K
-40.33%-675K
302.80%1.15M
-99.24%4K
End cash Position
-66.08%58.32M
-58.92%94.58M
-35.97%122.24M
-40.30%143.43M
-40.30%143.43M
-23.48%171.95M
-11.95%230.2M
16.91%190.92M
48.44%240.23M
48.44%240.23M
Free cash flow
11.83%-40.7M
24.83%-35.17M
5.57%-58.56M
24.79%-196.37M
26.46%-41.41M
15.06%-46.16M
31.09%-46.79M
24.86%-62.01M
23.81%-261.08M
20.18%-56.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.85%-40.61M24.87%-35.13M5.49%-58.5M22.42%-196.06M26.24%-41.34M15.20%-46.07M21.89%-46.76M24.98%-61.89M21.90%-252.73M20.09%-56.05M
Net income from continuing operations 16.90%-56.02M-7.35%-71.33M9.22%-60.17M28.35%-264.52M34.93%-64.39M14.32%-67.41M27.97%-66.45M33.28%-66.28M7.79%-369.21M0.55%-98.96M
Operating gains losses --------------------------------117.73%3.28M--0
Depreciation and amortization -6.53%1.89M-14.93%1.9M-14.19%1.92M3.64%8.5M-2.58%2M0.05%2.02M11.96%2.24M5.21%2.24M5.54%8.2M0.49%2.05M
Other non cash items 11,587.50%935K-42.86%944K-38.92%926K-88.85%4.25M-96.21%1.07M-98.76%8K159.34%1.65M-82.32%1.52M44.22%38.09M459.68%28.23M
Change In working capital -49.68%6.2M116.10%18.24M-129.01%-7.81M153.17%30.27M2,069.13%12.93M33.86%12.31M-31.97%8.44M66.73%-3.41M43.56%11.96M-97.48%596K
-Change in receivables 3.52%-1.86M437.23%8.1M-116.17%-765K86.20%-746K79.99%-1.15M5.48%-1.93M-134.91%-2.4M204.71%4.73M28.08%-5.41M-60.46%-5.72M
-Change in inventory 95.09%4.81M95.03%5.58M0.55%3.69M136.31%12.57M206.31%3.59M-43.21%2.46M215.23%2.86M-46.41%3.67M120.34%5.32M-5.14%-3.37M
-Change in prepaid assets -251.79%-2.88M-110.57%-8.13M-162.26%-1.32M38.79%-5.09M-12,113.95%-5.25M164.58%1.9M-130.63%-3.86M111.85%2.13M-135.78%-8.31M-100.43%-43K
-Change in payables and accrued expense -68.45%3.2M-28.68%7.7M49.31%-4.53M177.92%26.47M306.69%14.47M-8.65%10.13M304.31%10.8M-5,381.66%-8.93M-62.81%9.53M-83.32%3.56M
-Change in other working capital 1,291.50%2.94M379.27%4.99M2.52%-4.88M-127.15%-2.94M-79.45%1.27M80.08%-247K49.50%1.04M-196.29%-5.01M258.42%10.83M819.81%6.18M
Cash from discontinued investing activities
Operating cash flow 11.85%-40.61M24.87%-35.13M5.49%-58.5M22.42%-196.06M26.24%-41.34M15.20%-46.07M21.89%-46.76M24.98%-61.89M21.90%-252.73M20.09%-56.05M
Investing cash flow
Cash flow from continuing investing activities 0.00%-89K-27.78%-46K47.46%-62K-100.25%-312K73.46%-69K-368.42%-89K-100.06%-36K-100.17%-118K-11.90%126.33M-101.55%-260K
Net PPE purchase and sale 0.00%-89K-27.78%-46K47.46%-62K11.86%-312K73.46%-69K-368.42%-89K12.20%-36K-247.06%-118K88.26%-354K35.48%-260K
Net intangibles purchase and sale --------------0----------------49.21%-8M--0
Net investment purchase and sale --------------0-----------------16.95%134.68M--0
Cash from discontinued investing activities
Investing cash flow 0.00%-89K-27.78%-46K47.46%-62K-100.25%-312K73.46%-69K-368.42%-89K-100.06%-36K-100.17%-118K-11.90%126.33M-101.55%-260K
Financing cash flow
Cash flow from continuing financing activities 150.12%6.18M-89.36%9.14M183.02%37.86M-50.82%100.16M-81.67%13.17M-176.29%-12.33M-14.92%85.94M-8.66%13.38M69.86%203.64M443.96%71.84M
Net issuance payments of debt 111.47%6.18M-31.63%8.76M-30.92%9.22M59.56%-17.95M-86.36%9.73M-432.03%-53.84M-26.01%12.81M108.94%13.35M-138.06%-44.39M472.29%71.34M
Net common stock issuance --0-100.01%-8K--28.64M-52.60%116.92M--2.94M70,466.10%41.52M-12.50%72.47M--0--246.67M--0
Proceeds from stock option exercised by employees --0-40.24%392K--0-13.22%1.18M1.01%499K--0-24.25%656K1,250.00%27K-58.30%1.36M-33.24%494K
Cash from discontinued financing activities
Financing cash flow 150.12%6.18M-89.36%9.14M183.02%37.86M-50.82%100.16M-81.67%13.17M-176.29%-12.33M-14.92%85.94M-8.66%13.38M69.86%203.64M443.96%71.84M
Net cash flow
Beginning cash position -58.92%94.58M-35.97%122.24M-40.30%143.43M48.44%240.23M-23.48%171.95M-11.95%230.2M16.91%190.92M48.44%240.23M-27.06%161.83M11.53%224.7M
Current changes in cash 40.97%-34.52M-166.49%-26.03M57.44%-20.7M-224.56%-96.21M-281.96%-28.25M-53.16%-58.48M-60.03%39.15M-2,585.03%-48.63M228.04%77.24M138.64%15.52M
Effect of exchange rate changes -858.95%-1.74M-1,327.82%-1.63M27.85%-487K-151.13%-589K-7,000.00%-276K-84.23%229K-24.86%133K-40.33%-675K302.80%1.15M-99.24%4K
End cash Position -66.08%58.32M-58.92%94.58M-35.97%122.24M-40.30%143.43M-40.30%143.43M-23.48%171.95M-11.95%230.2M16.91%190.92M48.44%240.23M48.44%240.23M
Free cash flow 11.83%-40.7M24.83%-35.17M5.57%-58.56M24.79%-196.37M26.46%-41.41M15.06%-46.16M31.09%-46.79M24.86%-62.01M23.81%-261.08M20.18%-56.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data